Tony Tarragona-Fiol

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa Simek, Wasima Rida, Frances Priddy et al. · Journal of Virology · 2009 · 581 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger et al. · PLoS ONE · 2011 · 186 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. · PLoS ONE · 2010 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Michael C. Keefer, Jill Gilmour, Peter Hayes et al. · PLoS ONE · 2012 · 82 citations · Full text

Veterinary Medicine, Infectious Diseases, Immunization +16

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

Marcella Sarzotti‐Kelsoe, Josephine H. Cox, Naana Cleland et al. · PLoS Medicine · 2009 · 59 citations · Full text

Pharmacy, Clinical Sciences, Evidence-based Practice +11